The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adverse events (AEs) –derived biomarker in predicting clinical outcomes in patients with colorectal cancer (CRC) treated with immunotherapy (IC).
 
Dung-Tsa Chen
No Relationships to Disclose
 
Rutika Mehta
Honoraria - ASCO; Bristol-Myers Squibb
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; Legend Biotech; Merck; natera; Novartis; Seagen
Research Funding - NCCN
 
Richard Kim
Honoraria - Natera
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Eisai; Exelixis; Jazz Pharmaceuticals; Pfizer; Roche/Genentech; SERVIER; Taiho Oncology
Speakers' Bureau - AstraZeneca; Incyte
 
Jennifer Permuth
No Relationships to Disclose
 
Timothy Shaw
Patents, Royalties, Other Intellectual Property - TImothy Shaw reports a patent application in CAR T cell therapy US20220267425A1.; Timothy Shaw reports a patent application in CAR T cell therapy US20240216427A1.; Timothy Shaw reports a pending patent application on software for survival analysis.
Travel, Accommodations, Expenses - Aster's Insight; Aster's Insight; Aster's Insight
 
Dae Kim
No Relationships to Disclose